| Mr Daniel Walter Abel, MD | |
|
4630 Vistula Rd, Mishawaka, IN 46544-4000 | |
| (574) 647-1900 | |
| (574) 647-7206 |
| Full Name | Mr Daniel Walter Abel |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 14 Years |
| Location | 4630 Vistula Rd, Mishawaka, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508177619 | NPI | - | NPPES |
| P01302712 | Other | IN | RR MEDICARE |
| 000000820534 | Other | IN | BCBS |
| 201071850 | Medicaid | IN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 01072599A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital Of South Bend | South bend, IN | Hospital |
| Elkhart General Hospital | Elkhart, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Medical Group Inc | 1254243306 | 452 |
News Archive
Heart defibrillators, "small implants that save lives by sending an electrical jolt to interrupt a potentially fatal heart rhythm and restore normal beating," can pose a "challenge near life's end, for both patients and their families," The New York Times reports.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
Medicare Payment Advisory Commission officials at a meeting on Friday expressed concern over data showing differences in quality among newer Medicare Advantage plans and increasing enrollment in private fee-for-service MA plans, CQ HealthBeat reports.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II clinical study of Archexin, its clinical-stage oncology drug candidate.
New human and animal research released today demonstrates how experiences impact genes that influence behavior and health. Today's studies, presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health, provide new insights into how experience might produce long-term brain changes in behaviors like drug addiction and memory formation.
› Verified 7 days ago
| Entity Name | Beacon Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033161617 PECOS PAC ID: 1254243306 Enrollment ID: O20031105000657 |
News Archive
Heart defibrillators, "small implants that save lives by sending an electrical jolt to interrupt a potentially fatal heart rhythm and restore normal beating," can pose a "challenge near life's end, for both patients and their families," The New York Times reports.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
Medicare Payment Advisory Commission officials at a meeting on Friday expressed concern over data showing differences in quality among newer Medicare Advantage plans and increasing enrollment in private fee-for-service MA plans, CQ HealthBeat reports.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II clinical study of Archexin, its clinical-stage oncology drug candidate.
New human and animal research released today demonstrates how experiences impact genes that influence behavior and health. Today's studies, presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health, provide new insights into how experience might produce long-term brain changes in behaviors like drug addiction and memory formation.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Daniel Walter Abel, MD 710 N Niles Ave, South Bend, IN 46617-1924 Ph: (574) 647-1610 | Mr Daniel Walter Abel, MD 4630 Vistula Rd, Mishawaka, IN 46544-4000 Ph: (574) 647-1900 |
News Archive
Heart defibrillators, "small implants that save lives by sending an electrical jolt to interrupt a potentially fatal heart rhythm and restore normal beating," can pose a "challenge near life's end, for both patients and their families," The New York Times reports.
Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.
Medicare Payment Advisory Commission officials at a meeting on Friday expressed concern over data showing differences in quality among newer Medicare Advantage plans and increasing enrollment in private fee-for-service MA plans, CQ HealthBeat reports.
Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in oncology and CNS, today announced top-line results from a Phase II clinical study of Archexin, its clinical-stage oncology drug candidate.
New human and animal research released today demonstrates how experiences impact genes that influence behavior and health. Today's studies, presented at Neuroscience 2013, the annual meeting of the Society for Neuroscience and the world's largest source of emerging news about brain science and health, provide new insights into how experience might produce long-term brain changes in behaviors like drug addiction and memory formation.
› Verified 7 days ago
Theodore R Neumann, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 611 E Douglas Rd Ste 406, Mishawaka, IN 46545 Phone: 574-335-6580 | |
Dr. Josephine Schimizzi, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1505 South Spring Street, Mishawaka, IN 46544 Phone: 574-255-0726 | |
Dale Dennis Deardorff, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 420 W 4th St, Suite 180, Mishawaka, IN 46544 Phone: 574-247-3456 Fax: 574-247-3455 | |
James Mccarrey, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4630 Vistula Rd, Mishawaka, IN 46544 Phone: 574-647-1900 | |
Dr. Jack S. Bartoszek, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 615 Fulmer Rd, Mishawaka, IN 46544 Phone: 574-252-3085 Fax: 574-252-5906 | |
Dr. Lawrence R Curry, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 524 E Mckinley Ave, Mishawaka, IN 46545 Phone: 574-256-2556 Fax: 574-258-4278 | |
Jennifer Anne Pennington, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4630 Vistula Rd, Mishawaka, IN 46544 Phone: 574-647-1900 Fax: 574-254-7222 |